02 Dec Blogs Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting December 2, 2025 By shdrazeez@gmail.com 0 comments BOSTON, Dec. 2, 2025 /PRNewswire/ -- Solu Therapeutics, a biotechno... Continue reading